Evidence map›Paper›PMID 35194136›Full record

ArticleScientific reports2022

Altered TGFB1 regulated pathways promote accelerated tendon healing in the superhealer MRL/MpJ mouse.

Jacob G Kallenbach, Margaret A T Freeberg, David Abplanalp, Rahul G Alenchery, Raquel E Ajalik, Samantha Muscat, Jacquelyn A Myers, John M Ashton, Alayna Loiselle, Mark R Buckley and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Earlier proteoglycan turnover promotes higher efficiency matrix remodeling in MRL/MpJ tendons.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  11. Preclinical tendon and ligament models: Beyond the 3Rs (replacement, reduction, and refinement) to 5W1H (why, who, what, where, when, how).Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Review
  12. Article
  13. Reparative and Maladaptive Inflammation in Tendon Healing.Frontiers in bioengineering and biotechnology · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Jacob G Kallenbach *Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Margaret A T Freeberg *Department of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
David AbplanalpDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Rahul G AlencheryDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Raquel E AjalikDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Samantha MuscatCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.
Jacquelyn A MyersUR Genomics Research Center (GRC), University of Rochester Medical Center, Rochester, NY, USA.
John M AshtonUR Genomics Research Center (GRC), University of Rochester Medical Center, Rochester, NY, USA.
Alayna LoiselleCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY, USA.
Mark R BuckleyDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA.
Andre J van WijnenDepartment of Biochemistry, University of Vermont, Burlington, VT, USA.
Hani A AwadDepartment of Biomedical Engineering, University of Rochester, Rochester, NY, USA. hani_awad@urmc.rochester.edu.
University of Rochester · USUniversity of Rochester Medical Center · USUniversity of Vermont · US

Funding

Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)P30AR069655 · NIAMS · UNIVERSITY OF ROCHESTER · PI Edward M. Schwarz · 2016 to 2026
$7.8M
Molecular Control of Bone FormationR01AR049069 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI WESTENDORF, JENNIFER J · 2003 to 2021
$5.8M
Engineering scarless repair of flexor tendon injuriesR01AR056696 · NIAMS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, BENOIT, DANIELLE S. · 2009 to 2019
$3.6M
Training in Orthopaedic Researchhttps://apps.era.nih.gov/grantfolder/viewInternalGF.era?applId=8841318&folderId=90T32AR053459 · NIAMS · UNIVERSITY OF ROCHESTER · PI ZUSCIK, MICHAEL J · 2006 to 2017
$3.4M
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testingUH3TR003281 · NCATS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, MCGRATH, JAMES L · 2022 to 2024
$2.2M
Modulating Cell-fate to Promote Regenerative Tendon HealingR01AR077527 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2021 to 2025
$2.0M
s100a4 Signaling in Fibrotic Diabetic Tendon HealingR01AR073169 · NIAMS · UNIVERSITY OF ROCHESTER · PI LOISELLE, ALAYNA · 2018 to 2022
$1.7M
Training in Musculoskeletal Science: Comprehensive Training in Pain StudiesT32AR076950 · NIAMS · UNIVERSITY OF ROCHESTER · PI Hani A Awad, Laura M Calvi · 2020 to 2026
$1.7M
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing: MPS Database EngagementUG3TR003281 · NCATS · UNIVERSITY OF ROCHESTER · PI AWAD, HANI A, MCGRATH, JAMES L · 2020 to 2021
$1.6M
NCATS NIH HHS UG3 TR003281NCATS NIH HHS UG3TR003281NCATS NIH HHS UH3 TR003281NIAMS NIH HHS P30 AR069655NIAMS NIH HHS R01 AR049069NIAMS NIH HHS R01AR049069NIAMS NIH HHS R01 AR056696NIAMS NIH HHS R01AR056696NIAMS NIH HHS R01 AR073169NIAMS NIH HHS R01AR073169NIAMS NIH HHS R01 AR077527NIAMS NIH HHS T32 AR053459NIAMS NIH HHS T32AR053459NIAMS NIH HHS T32 AR076950NIAMS NIH HHS T32AR076950
6 · The paper itself

Abstract

To better understand the molecular mechanisms of tendon healing, we investigated the Murphy Roth's Large (MRL) mouse, which is considered a model of mammalian tissue regeneration. We show that compared to C57Bl/6J (C57) mice, injured MRL tendons have reduced fibrotic adhesions and cellular proliferation, with accelerated improvements in biomechanical properties. RNA-seq analysis revealed that differentially expressed genes in the C57 healing tendon at 7 days post injury were functionally linked to fibrosis, immune system signaling and extracellular matrix (ECM) organization, while the differentially expressed genes in the MRL injured tendon were dominated by cell cycle pathways. These gene expression changes were associated with increased α-SMA+ myofibroblast and F4/80+ macrophage activation and abundant BCL-2 expression in the C57 injured tendons. Transcriptional analysis of upstream regulators using Ingenuity Pathway Analysis showed positive enrichment of TGFB1 in both C57 and MRL healing tendons, but with different downstream transcriptional effects. MRL tendons exhibited of cell cycle regulatory genes, with negative enrichment of the cell senescence-related regulators, compared to the positively-enriched inflammatory and fibrotic (ECM organization) pathways in the C57 tendons. Serum cytokine analysis revealed decreased levels of circulating senescence-associated circulatory proteins in response to injury in the MRL mice compared to the C57 mice. These data collectively demonstrate altered TGFB1 regulated inflammatory, fibrosis, and cell cycle pathways in flexor tendon repair in MRL mice, and could give cues to improved tendon healing.

Indexed as

AnimalsCell AdhesionCell CycleCell ProliferationFibrosisGene Expression Regulation, DevelopmentalInflammationMiceMice, Inbred C57BLMice, Inbred MRL lprModels, AnimalRegenerationSignal TransductionTendon InjuriesTendonsTransforming Growth Factor beta1Tgfb1 protein, mouseTransforming Growth Factor beta1

Identifiers

PMID35194136
PMCPMC8863792
OpenAlexW4220890224

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.